Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Checkpoint Therapeutics, Inc. - Common Stock
(NQ:
CKPT
)
3.750
+0.380 (+11.28%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,261,027
Open
3.350
Bid (Size)
3.700 (3)
Ask (Size)
3.750 (2)
Prev. Close
3.370
Today's Range
3.330 - 3.760
52wk Range
1.380 - 4.500
Shares Outstanding
45,095,500
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Oncology Advancements Accelerate Amid Rising Early-Onset Cancer Diagnoses
December 20, 2024
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:CRDF),(NASDAQ:PSNL),(NASDAQ:TEM),(NASDAQ:CKPT) EQNX::TICKER_END
Via
FinancialNewsMedia
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
COVID-19
FDA Approves Checkpoint Therapeutics' Skin Cancer Drug One Year After Rejection
December 16, 2024
Checkpoint Therapeutics' Unloxcyt wins FDA approval for advanced cSCC, marking the company's entry into the U.S. market, valued over $1 billion annually.
Via
Benzinga
Exposures
Product Safety
Performance
YTD
+71.23%
+71.23%
1 Month
+10.95%
+10.95%
3 Month
+55.60%
+55.60%
6 Month
+108.33%
+108.33%
1 Year
+103.80%
+103.80%
More News
Read More
US Stocks To Open Higher Ahead Of Fed's Decision This Week: Analyst Says 'Santa Comes Later In December'
December 16, 2024
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
CKPT Stock Earnings: Checkpoint Therapeutics Beats EPS, Beats Revenue for Q2 2024
August 12, 2024
Via
InvestorPlace
CHECKPOINT ALERT: Bragar Eagel & Squire, P.C. is Investigating Checkpoint Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
June 05, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
CKPT DEADLINE TODAY: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important June 4 Deadline in Securities Class Action - CKPT
June 04, 2024
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
CKPT DEADLINE TODAY: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important June 4 Deadline in Securities Class Action - CKPT
June 04, 2024
Via
TheNewswire.com
Topics
Lawsuit
Exposures
Financial
Legal
DEADLINE TODAY: The Schall Law Firm Encourages Investors in Checkpoint Therapeutics, Inc. with Losses to Contact the Firm
June 04, 2024
From
Schall Law
Via
GlobeNewswire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Checkpoint Therapeutics, Inc. (CKPT)
June 03, 2024
From
The Law Offices of Frank R. Cruz
Via
Business Wire
CKPT FINAL DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important June 4 Deadline in Securities Class Action - CKPT
June 03, 2024
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
CKPT FINAL DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important June 4 Deadline in Securities Class Action - CKPT
June 03, 2024
Via
TheNewswire.com
Topics
Lawsuit
Exposures
Financial
Legal
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Checkpoint
June 03, 2024
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
CHECKPOINT DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Checkpoint Therapeutics, Inc. and Encourages Investors to Contact the Firm
May 31, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
ROSEN, A LEADING LAW FIRM, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important June 4 Deadline in Securities Class Action – CKPT
May 30, 2024
From
The Rosen Law Firm PA
Via
GlobeNewswire
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Checkpoint
May 30, 2024
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
7-DAY DEADLINE ALERT: The Schall Law Firm Encourages Investors in Checkpoint Therapeutics, Inc. with Losses to Contact the Firm
May 28, 2024
From
Schall Law
Via
GlobeNewswire
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important June 4 Deadline in Securities Class Action - CKPT
May 26, 2024
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important June 4 Deadline in Securities Class Action - CKPT
May 26, 2024
Via
TheNewswire.com
Topics
Lawsuit
Exposures
Financial
Legal
CKPT SHAREHOLDER ALERT: TOP RANKED ROSEN LAW FIRM Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important June 4 Deadline in Securities Class Action – CKPT
May 23, 2024
From
The Rosen Law Firm PA
Via
GlobeNewswire
SHAREHOLDER ALERT Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Checkpoint
May 22, 2024
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
June 4th Lead Plaintiff Deadline Approaching in Class Action Against Checkpoint Therapeutics, Inc. – Contact Robbins LLP Today
May 21, 2024
From
Robbins LLP
Via
GlobeNewswire
INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Checkpoint Therapeutics, Inc. with Losses to Contact the Firm
May 21, 2024
From
Schall Law
Via
GlobeNewswire
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CKPT
May 20, 2024
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CKPT
May 20, 2024
Via
TheNewswire.com
Topics
Lawsuit
Exposures
Financial
Legal
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CKPT
May 17, 2024
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.